Literature DB >> 17466904

Vaccination with dendritic cells transfected with mRNA-encoded folate-receptor-alpha for relapsed metastatic ovarian cancer.

Juan José Hernando1, Tjoung-Won Park, Hans-Peter Fischer, Oliver Zivanovic, Michael Braun, Martin Pölcher, Ursula Grünn, Claudia Leutner, Bernd Pötzsch, Walther Kuhn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17466904     DOI： 10.1016/S1470-2045(07)70142-0

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  19 in total

1.  Induction of antigen-specific cytotoxic T lymphocytes by using monocyte-derived DCs transfected with in vitro-transcribed WT1 or SART1 mRNA.

Authors:  Miwako Narita; Nozomi Tochiki; Anri Saitoh; Norihiro Watanabe; Masami Kaji; Noriyuki Satoh; Akie Yamahira; Takeshi Nakamura; Masayoshi Masuko; Tatsuo Furukawa; Ken Toba; Ichiro Fuse; Yoshifusa Aizawa; Masuhiro Takahashi
Journal:  Med Oncol       Date:  2008-12-05       Impact factor: 3.064

Review 2.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

3.  Immunity and immune suppression in human ovarian cancer.

Authors:  Claudia C Preston; Ellen L Goode; Lynn C Hartmann; Kimberly R Kalli; Keith L Knutson
Journal:  Immunotherapy       Date:  2011-04       Impact factor: 4.196

Review 4.  Ovarian cancer immunotherapy: opportunities, progresses and challenges.

Authors:  Bei Liu; John Nash; Carolyn Runowicz; Helen Swede; Richard Stevens; Zihai Li
Journal:  J Hematol Oncol       Date:  2010-02-10       Impact factor: 17.388

Review 5.  Cellular immunotherapy for ovarian cancer.

Authors:  Martin J Cannon; Timothy J O'Brien
Journal:  Expert Opin Biol Ther       Date:  2009-06       Impact factor: 4.388

Review 6.  Exploiting the folate receptor α in oncology.

Authors:  Mariana Scaranti; Elena Cojocaru; Susana Banerjee; Udai Banerji
Journal:  Nat Rev Clin Oncol       Date:  2020-03-09       Impact factor: 66.675

7.  Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancer.

Authors:  Yingjuan Lu; Patrick J Klein; Elaine Westrick; Le-Cun Xu; Hari Krishna R Santhapuram; Alicia Bloomfield; Stephen J Howard; Iontcho R Vlahov; P Ron Ellis; Philip S Low; Christopher P Leamon
Journal:  AAPS J       Date:  2009-09       Impact factor: 4.009

Review 8.  Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.

Authors:  Yu-Zhe Chen; Xing-Lei Yao; Yasuhiko Tabata; Shinsaku Nakagawa; Jian-Qing Gao
Journal:  Clin Dev Immunol       Date:  2010-12-20

9.  A current review of targeted therapeutics for ovarian cancer.

Authors:  Susana M Campos; Sue Ghosh
Journal:  J Oncol       Date:  2010-01-03       Impact factor: 4.375

Review 10.  Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer.

Authors:  Vincent Lavoué; Aurélie Thédrez; Jean Levêque; Fabrice Foucher; Sébastien Henno; Vincent Jauffret; Marc-Antoine Belaud-Rotureau; Veronique Catros; Florian Cabillic
Journal:  J Transl Med       Date:  2013-06-13       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.